More Americans living 5 years after cancer diagnosis
Digest more
A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...
WASHINGTON - There's more advice on the contentious issue of prostate cancer screening: A leading group of cancer specialists says the decision hinges in part on a man's life expectancy.
Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients with undetectable PSA levels.
A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback